HAE - Company ID 0000313143
HAEMONETICS CORP (HAE) reported net income of $97.31M for fiscal year 2026, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2026 | $97.31M | -42.0% |
| FY 2025 | $167.68M | +42.6% |
| FY 2024 | $117.56M | +1.9% |
| FY 2023 | $115.40M | +166.1% |
| FY 2022 | $43.38M | -45.4% |
| FY 2021 | $79.47M | +3.8% |
| FY 2020 | $76.53M | +39.1% |
| FY 2019 | $55.02M | +20.7% |
| FY 2018 |
HAEMONETICS CORP (HAE) reported net income of $97.31M for fiscal year 2026, as filed in its audited annual report with the SEC.
Between fiscal 2012 and fiscal 2026, HAEMONETICS CORP's net income grew from $66.89M to $97.31M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $45.57M |
| +273.5% |
| FY 2017 | -$26.27M | +52.7% |
| FY 2016 | -$55.58M | -428.9% |
| FY 2015 | $16.90M | -51.9% |
| FY 2014 | $35.15M | -9.4% |
| FY 2013 | $38.80M | -42.0% |
| FY 2012 | $66.89M | - |